Atlas Trials

Dose-Escalation Study of GSK2126458

Clinical trial NCT00972686 · COMPLETED

Trial details

NCT number
NCT00972686
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumours
Start date
2009-08-31
Primary completion
2012-12-12
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.